肝细胞癌微血管侵犯的预测及治疗进展

Research advances in microvascular invasion in hepatocellular carcinoma

尽管目前肝细胞癌(HCC)采用联合多学科、多种方式的综合治疗,但仍有很大部分患者预后较差。现有研究表明微血管侵犯(MVI)是HCC发生不良预后的重要因素之一,但目前MVI只能通过术后病理证实。分析总结了近年来有关于MVI发生的相关因素及治疗措施,以更深入的了解MVI的研究进展。

Although hepatocellular carcinoma(HCC)is treated with a combination of multiple disciplines and methods,there are still a large number of patients with poor prognosis.Current studies have shown that microvascular invasion(MVI)is one of the important factors for poor prognosis of HCC,but MVI can only be confirmed by postoperative pathology.This article analyzes and summarizes the factors and treatment measures for MVI in recent years,so as to better understand the research advances in MVI.